BALANCED SALT SOLUTION

BALANCED SALT SOLUTION was reported 1293 times

BALANCED SALT SOLUTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AQUEOUS FIBRIN 43 0.8431
1 TOXIC ANTERIOR SEGMENT SYNDROME 509 0.4665
2 DIFFUSE LAMELLAR KERATITIS 18 0.4286
3 ANTERIOR CHAMBER FIBRIN 47 0.3643
4 MEIBOMIAN GLAND DISCHARGE 2 0.2857
5 ANTERIOR CHAMBER CRYSTALLISATION 2 0.2857
6 FIBRIN 8 0.1860
7 POSTERIOR SEGMENT OF EYE ANOMALY 1 0.1429
8 INJURY OF CONJUNCTIVA 1 0.1429
9 IRIS BOMBE 2 0.1333
10 HYPOPYON 109 0.1316
11 EYE INFECTION INTRAOCULAR 10 0.1282
12 CORNEAL FLAP COMPLICATION 2 0.1111
13 ANTERIOR CHAMBER PIGMENTATION 2 0.1000
14 PUPILLARY BLOCK 3 0.0938
15 PROLIFERATIVE VITREORETINOPATHY 1 0.0909
16 ANTERIOR CHAMBER CELL 63 0.0882
17 ANTERIOR CHAMBER DISORDER 19 0.0826
18 VITREOUS LOSS 5 0.0806
19 ANTERIOR CHAMBER FLARE 17 0.0730
20 CYCLITIC MEMBRANE 1 0.0714
21 ANTERIOR CHAMBER OPACITY 1 0.0714
22 PRODUCT STERILITY LACKING 6 0.0714
23 IRIS VASCULAR DISORDER 1 0.0667
24 CORNEAL STRIAE 4 0.0563
25 ENDOPHTHALMITIS 313 0.0521
26 FIBRIN ABNORMAL 1 0.0500
27 CATARACT OPERATION COMPLICATION 25 0.0491
28 BURKHOLDERIA TEST POSITIVE 6 0.0484
29 CORNEAL INFILTRATES 14 0.0446
30 CORNEAL OEDEMA 99 0.0441
31 CANDIDA ENDOPHTHALMITIS 5 0.0410
32 OPTIC DISC HYPERAEMIA 1 0.0400
33 FLAT ANTERIOR CHAMBER OF EYE 7 0.0391
34 ANTERIOR CHAMBER INFLAMMATION 23 0.0387
35 POSTERIOR CAPSULE RUPTURE 3 0.0380
36 VITREOUS FIBRIN 1 0.0357
37 EYE OPERATION COMPLICATION 5 0.0305
38 FOREIGN BODY IN EYE 28 0.0292
39 CORNEAL INFECTION 6 0.0276
40 CYCLITIS 1 0.0270
41 CORNEAL OPACITY 35 0.0256
42 PUPILLARY DEFORMITY 2 0.0250
43 CORNEAL EPITHELIUM DEFECT 14 0.0241
44 KERATOPLASTY 1 0.0238
45 VITRITIS 44 0.0237
46 BACTERIAL ENDOPHTHALMITIS 6 0.0226
47 POSTOPERATIVE INFECTION 10 0.0211
48 PSEUDOENDOPHTHALMITIS 2 0.0202
49 VITREAL CELLS 4 0.0198
50 IRIS HAEMORRHAGE 1 0.0196
51 VITREOUS HAZE 3 0.0196
52 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 1 0.0192
53 POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II 1 0.0185
54 CONJUNCTIVAL BLEB 1 0.0185
55 HORMONE REPLACEMENT THERAPY 1 0.0172
56 PRODUCT STERILITY ISSUE 2 0.0163
57 LUNG ASSIST DEVICE THERAPY 1 0.0161
58 ANISOMETROPIA 1 0.0154
59 DEVELOPMENTAL GLAUCOMA 1 0.0154
60 KERATOPATHY 24 0.0152
61 POST PROCEDURAL INFLAMMATION 9 0.0145
62 THERMAL BURNS OF EYE 3 0.0133
63 NON-INFECTIOUS ENDOPHTHALMITIS 11 0.0130
64 MIXED DEAFNESS 1 0.0127
65 HYPOTONY OF EYE 5 0.0119
66 THERAPEUTIC PRODUCT CONTAMINATION 3 0.0117
67 CILIARY HYPERAEMIA 1 0.0105
68 PIGMENT DISPERSION SYNDROME 1 0.0105
69 EYE INFLAMMATION 100 0.0105
70 EYE INFECTION STAPHYLOCOCCAL 3 0.0104
71 DEAFNESS PERMANENT 2 0.0102
72 OTOSCLEROSIS 1 0.0100
73 CORNEAL EXFOLIATION 1 0.0098
74 IRIS ATROPHY 2 0.0097
75 CORNEAL ABSCESS 1 0.0093
76 VITREOUS ADHESIONS 1 0.0087
77 VITREOUS DISORDER 4 0.0083
78 EYE OEDEMA 20 0.0081
79 ATROPHY OF GLOBE 1 0.0078
80 IRIDOCELE 1 0.0077
81 EYE INFECTION BACTERIAL 4 0.0072
82 LENS DISORDER 2 0.0069
83 HAIR GROWTH RATE ABNORMAL 1 0.0068
84 OPEN GLOBE INJURY 1 0.0061
85 VITREOUS OPACITIES 5 0.0059
86 KERATITIS 18 0.0059
87 IRIS ADHESIONS 3 0.0058
88 HYPHAEMA 3 0.0057
89 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
90 PRODUCT COMPOUNDING QUALITY ISSUE 2 0.0055
91 CORNEAL DISORDER 12 0.0055
92 IRIDOCYCLITIS 17 0.0054
93 INTRA-OCULAR INJECTION COMPLICATION 1 0.0044
94 ENDOTHELIAL DYSFUNCTION 1 0.0043
95 CALCIUM IONISED DECREASED 1 0.0041
96 POST PROCEDURAL COMPLICATION 79 0.0041
97 CORNEAL DEPOSITS 3 0.0040
98 CORNEAL SCAR 2 0.0040
99 IRITIS 12 0.0039
100 MULTIPLE USE OF SINGLE-USE PRODUCT 22 0.0039
101 CORNEAL THINNING 1 0.0039
102 NEOVASCULARISATION 1 0.0038
103 METAMORPHOPSIA 7 0.0038
104 DEPOSIT EYE 1 0.0037
105 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
106 CHOROIDAL DETACHMENT 2 0.0036
107 EPIRETINAL MEMBRANE 1 0.0036
108 VISUAL ACUITY TESTS ABNORMAL 2 0.0036
109 PUPIL FIXED 6 0.0035
110 ENDOCRINE OPHTHALMOPATHY 3 0.0035
111 REFRACTION DISORDER 1 0.0034
112 GRAFT COMPLICATION 2 0.0034
113 EYE BURNS 2 0.0034
114 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 1 0.0032
115 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 4 0.0032
116 CYSTOID MACULAR OEDEMA 6 0.0032
117 INTRAOCULAR PRESSURE INCREASED 39 0.0030
118 SURGICAL PROCEDURE REPEATED 2 0.0029
119 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
120 EYE ROLLING 2 0.0028
121 BIPOLAR II DISORDER 1 0.0028
122 MULTIPLE DRUG THERAPY 2 0.0027
123 ANISOCORIA 1 0.0026
124 PUPILS UNEQUAL 3 0.0026
125 EYE INFECTION FUNGAL 1 0.0026
126 STREPTOCOCCAL INFECTION 14 0.0025
127 CONJUNCTIVAL HYPERAEMIA 8 0.0022
128 BACTERIAL TEST POSITIVE 5 0.0022
129 POST PROCEDURAL INFECTION 18 0.0022
130 PUNCTATE KERATITIS 2 0.0022
131 KERATIC PRECIPITATES 1 0.0021
132 ASTIGMATISM 3 0.0020
133 GLARE 1 0.0019
134 CONJUNCTIVAL OEDEMA 2 0.0019
135 INTRAOCULAR PRESSURE DECREASED 1 0.0019
136 PRODUCT CLEANING INADEQUATE 5 0.0019
137 IRIS DISORDER 1 0.0019
138 CORNEAL EROSION 1 0.0019
139 BODY FAT DISORDER 1 0.0018
140 UVEITIS 25 0.0018
141 TENOSYNOVITIS STENOSANS 1 0.0018
142 CELLULITIS ORBITAL 1 0.0017
143 BLINDNESS UNILATERAL 24 0.0017
144 VISUAL ACUITY REDUCED 55 0.0017
145 RETINAL TEAR 4 0.0016
146 CORNEAL PERFORATION 1 0.0016
147 FOREIGN BODY SENSATION IN EYES 10 0.0016
148 RUPTURED CEREBRAL ANEURYSM 1 0.0015
149 ANAESTHETIC COMPLICATION 4 0.0015
150 MACULAR FIBROSIS 1 0.0015
151 ULCERATIVE KERATITIS 4 0.0015
152 CORNEAL ABRASION 2 0.0015
153 FUSARIUM INFECTION 1 0.0014
154 MACULAR OEDEMA 8 0.0014
155 EYE INFECTION 16 0.0014
156 SUTURE RELATED COMPLICATION 1 0.0014
157 CONJUNCTIVITIS 25 0.0013
158 RETINAL DETACHMENT 12 0.0013
159 CORNEAL TRANSPLANT 1 0.0013
160 CHOROIDAL EFFUSION 1 0.0012
161 EYE PAIN 70 0.0012
162 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
163 VITREOUS FLOATERS 12 0.0012
164 DEAFNESS NEUROSENSORY 4 0.0012
165 CULTURE POSITIVE 1 0.0012
166 SEROUS RETINAL DETACHMENT 1 0.0012
167 PRODUCT CONTAINER ISSUE 10 0.0012
168 OESOPHAGEAL OBSTRUCTION 1 0.0012
169 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
170 CERUMEN IMPACTION 1 0.0011
171 PUPILLARY REFLEX IMPAIRED 2 0.0011
172 ENDOTRACHEAL INTUBATION 3 0.0011
173 HYPERMETROPIA 1 0.0011
174 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
175 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
176 OCULAR HYPERAEMIA 45 0.0009
177 OCULAR TOXICITY 1 0.0009
178 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
179 OCULAR DISCOMFORT 10 0.0009
180 OPTIC NERVE INJURY 1 0.0009
181 MYOPIA 2 0.0008
182 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
183 CATHETER SITE INFECTION 3 0.0008
184 RETINAL ARTERY OCCLUSION 2 0.0008
185 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
186 BLOOD BILIRUBIN ABNORMAL 1 0.0008
187 STENOTROPHOMONAS INFECTION 1 0.0007
188 VITREOUS HAEMORRHAGE 2 0.0007
189 PRODUCT LEAKAGE 4 0.0007
190 CHORIORETINOPATHY 1 0.0007
191 AXILLARY PAIN 1 0.0007
192 BLOOD CULTURE POSITIVE 2 0.0007
193 EYE INJURY 2 0.0007
194 PROCEDURAL COMPLICATION 5 0.0007
195 PRODUCT DEPOSIT 1 0.0006
196 RESPIRATORY RATE DECREASED 2 0.0006
197 SCLERITIS 1 0.0006
198 POOR QUALITY DRUG ADMINISTERED 4 0.0006
199 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
200 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
201 INFLAMMATION 28 0.0005
202 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
203 VISION BLURRED 74 0.0005
204 EMPYEMA 1 0.0005
205 PHOTOPHOBIA 9 0.0005
206 LUNG ABSCESS 1 0.0005
207 DEVICE MATERIAL ISSUE 1 0.0005
208 ABNORMAL SENSATION IN EYE 2 0.0005
209 LACRIMATION INCREASED 14 0.0005
210 REACTION TO DRUG EXCIPIENTS 1 0.0005
211 ACCIDENT AT WORK 1 0.0005
212 PHYSICAL DISABILITY 2 0.0005
213 VISUAL IMPAIRMENT 54 0.0004
214 PANCREATITIS NECROTISING 1 0.0004
215 RETINAL HAEMORRHAGE 3 0.0004
216 MEDICATION RESIDUE PRESENT 2 0.0004
217 TRANSPLANT FAILURE 1 0.0004
218 EXPIRED DRUG ADMINISTERED 2 0.0004
219 STAPHYLOCOCCAL INFECTION 13 0.0004
220 NOCARDIOSIS 1 0.0004
221 MYDRIASIS 5 0.0004
222 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
223 RETINAL DISORDER 1 0.0004
224 EYE IRRITATION 22 0.0004
225 ANIMAL BITE 1 0.0004
226 ALCOHOL ABUSE 1 0.0004
227 RETINAL VEIN OCCLUSION 1 0.0003
228 MEDICATION ERROR 19 0.0003
229 STRABISMUS 1 0.0003
230 METABOLIC ENCEPHALOPATHY 1 0.0003
231 ADVERSE REACTION 4 0.0003
232 BLINDNESS 12 0.0003
233 DIABETIC RETINOPATHY 1 0.0003
234 WOUND COMPLICATION 1 0.0003
235 EYE DISCHARGE 3 0.0003
236 PRODUCT QUALITY ISSUE 39 0.0003
237 HEART RATE DECREASED 10 0.0003
238 TYPE I HYPERSENSITIVITY 1 0.0003
239 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
240 EYE PRURITUS 9 0.0003
241 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
242 EPIGASTRIC DISCOMFORT 1 0.0003
243 PRODUCT USE COMPLAINT 4 0.0003
244 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
245 PSEUDOMONAS INFECTION 2 0.0002
246 NAIL DISORDER 2 0.0002
247 BLOOD PRESSURE DECREASED 15 0.0002
248 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
249 ISCHAEMIA 1 0.0002
250 IMPAIRED QUALITY OF LIFE 3 0.0002
251 ENTEROCOCCAL INFECTION 1 0.0002
252 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
253 ASTHENOPIA 1 0.0002
254 VISUAL DISTURBANCE 1 0.0002
255 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
256 SYMPTOM RECURRENCE 1 0.0002
257 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
258 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
259 EYE SWELLING 6 0.0002
260 BACTERIAL INFECTION 3 0.0002
261 SWELLING OF EYELID 1 0.0002
262 EYE HAEMORRHAGE 2 0.0001
263 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
264 POSTOPERATIVE WOUND INFECTION 1 0.0001
265 PRODUCT LABEL ISSUE 1 0.0001
266 DRUG TOXICITY 2 0.0001
267 ONYCHOCLASIS 1 0.0001
268 HAIR GROWTH ABNORMAL 1 0.0001
269 PRODUCT SUPPLY ISSUE 1 0.0001
270 BLINDNESS TRANSIENT 1 0.0001
271 ECONOMIC PROBLEM 2 0.0001
272 TINNITUS 6 0.0001
273 APHTHOUS ULCER 1 0.0001
274 MIOSIS 1 0.0001
275 DECUBITUS ULCER 1 0.0001
276 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
277 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
278 DIARRHOEA HAEMORRHAGIC 1 0.0001
279 LACERATION 1 0.0001
280 PRODUCT PACKAGING ISSUE 1 0.0001
281 GLAUCOMA 2 0.0001
282 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
283 SINUS BRADYCARDIA 1 0.0001
284 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
285 OFF LABEL USE 86 0.0001
286 NEUTROPHIL COUNT INCREASED 1 0.0001
287 EAR DISCOMFORT 1 0.0001
288 EYE DISORDER 3 0.0001
289 THERAPY NON-RESPONDER 4 0.0001
290 EYELID OEDEMA 1 0.0001
291 HIATUS HERNIA 1 0.0001
292 OEDEMA 4 0.0001
293 DEVICE OCCLUSION 1 0.0001
294 CATARACT 4 0.0001
295 BLOOD COUNT ABNORMAL 1 0.0001
296 OSTEOPENIA 1 0.0001
297 DEVICE RELATED INFECTION 1 0.0001
298 THYROID DISORDER 1 0.0001
299 PNEUMOTHORAX 1 0.0001
300 PHOTOSENSITIVITY REACTION 1 0.0001
301 PRODUCT USE ISSUE 11 0.0001
302 SCAR 1 0.0001
303 COLD SWEAT 1 0.0001
304 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
305 HYPERHIDROSIS 7 0.0001
306 SLEEP APNOEA SYNDROME 1 0.0001
307 DISABILITY 1 0.0001
308 DISCOMFORT 3 0.0000
309 IMPAIRED WORK ABILITY 1 0.0000
310 DEVICE DISLOCATION 2 0.0000
311 FEBRILE NEUTROPENIA 3 0.0000
312 EMOTIONAL DISTRESS 5 0.0000
313 NEURALGIA 1 0.0000
314 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
315 AGEUSIA 1 0.0000
316 DRY EYE 2 0.0000
317 THERAPY CESSATION 2 0.0000
318 ANAPHYLACTIC SHOCK 1 0.0000
319 UNRESPONSIVE TO STIMULI 1 0.0000
320 LIMB INJURY 1 0.0000
321 PNEUMONITIS 1 0.0000
322 FEELING COLD 1 0.0000
323 TOXICITY TO VARIOUS AGENTS 6 0.0000
324 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
325 RED BLOOD CELL COUNT DECREASED 1 0.0000
326 CORONARY ARTERY DISEASE 1 0.0000
327 IMPAIRED HEALING 1 0.0000
328 FUNGAL INFECTION 1 0.0000
329 INJURY 2 0.0000
330 C-REACTIVE PROTEIN INCREASED 1 0.0000
331 RESPIRATORY FAILURE 2 0.0000
332 MUSCLE SPASMS 5 0.0000
333 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
334 CHILLS 3 0.0000
335 DISORIENTATION 1 0.0000
336 DEVICE BREAKAGE 1 0.0000
337 DYSKINESIA 1 0.0000
338 RECTAL HAEMORRHAGE 1 0.0000
339 COVID-19 4 0.0000
340 DEVICE ISSUE 2 0.0000
341 NAUSEA 17 0.0000
342 COGNITIVE DISORDER 1 0.0000
343 SYNCOPE 2 0.0000
344 DRUG EFFECT DECREASED 1 0.0000
345 RASH PRURITIC 1 0.0000
346 TREATMENT NONCOMPLIANCE 1 0.0000
347 OXYGEN SATURATION DECREASED 1 0.0000
348 HYPONATRAEMIA 1 0.0000
349 ANXIETY 5 0.0000
350 PRODUCT SUBSTITUTION ISSUE 1 0.0000
351 NASAL CONGESTION 1 0.0000
352 DISEASE PROGRESSION 2 0.0000
353 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
354 JOINT SWELLING 2 0.0000
355 THERAPEUTIC RESPONSE DECREASED 1 0.0000
356 FEELING HOT 1 0.0000
357 HEADACHE 10 0.0000
358 SWELLING FACE 1 0.0000
359 BURNING SENSATION 1 0.0000
360 DEVICE MALFUNCTION 1 0.0000
361 HOT FLUSH 1 0.0000
362 PAIN 8 0.0000
363 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
364 INFLUENZA LIKE ILLNESS 1 0.0000
365 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
366 INTENTIONAL PRODUCT MISUSE 1 0.0000
367 NO ADVERSE EVENT 2 0.0000
368 OROPHARYNGEAL PAIN 1 0.0000
369 HYPERSENSITIVITY 2 0.0000
370 COUGH 3 0.0000
371 DYSPHAGIA 1 0.0000
372 NEUROPATHY PERIPHERAL 1 0.0000
373 CONTUSION 1 0.0000
374 ALOPECIA 2 0.0000
375 CHEST DISCOMFORT 1 0.0000
376 ABDOMINAL PAIN UPPER 2 0.0000
377 HAEMORRHAGE 1 0.0000
378 PLATELET COUNT DECREASED 1 0.0000
379 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
380 SEIZURE 1 0.0000
381 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
382 OEDEMA PERIPHERAL 1 0.0000
383 LOSS OF CONSCIOUSNESS 1 0.0000
384 DIARRHOEA 5 0.0000
385 INFECTION 1 0.0000
386 HYPOAESTHESIA 1 0.0000
387 CONDITION AGGRAVATED 2 0.0000
388 BLOOD PRESSURE INCREASED 1 0.0000
389 PERIPHERAL SWELLING 1 0.0000
390 PARAESTHESIA 1 0.0000
391 TREMOR 1 0.0000
392 ABDOMINAL DISCOMFORT 1 0.0000
393 MYALGIA 1 0.0000
394 PYREXIA 2 0.0000
395 NASOPHARYNGITIS 1 0.0000
396 CHEST PAIN 1 0.0000
397 BLOOD GLUCOSE INCREASED 1 0.0000
398 DYSPNOEA 3 0.0000
399 ANAEMIA 1 0.0000
400 HYPOTENSION 1 0.0000
401 SOMNOLENCE 1 0.0000
402 HYPERTENSION 1 0.0000
403 DEATH 4 0.0000
404 DIZZINESS 2 0.0000
405 FATIGUE 3 0.0000
406 WEIGHT DECREASED 1 0.0000
407 PNEUMONIA 1 0.0000
408 PRURITUS 1 0.0000
409 DRUG INEFFECTIVE 2 0.0000